Santa Barbara, California-based hair products company Olaplex wrapped an upsized initial public offering, selling 73.7 million shares at $21 each, well above the $17 to $19 range.
The stock opened on the Nasdaq under the ticker symbol OLPX at $25 per share.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $19.08 |
|---|---|
| 52-week range | $20.28 - $30.41 |
| 50-day moving average | $26.09 |
| 200-day moving average | $26.16 |
| Wall St. target price | $34.64 |
| PE ratio | 109.7861 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $0.19 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $19.08 from 2022-01-21
| 1 week (2022-01-18) | -8.45% |
|---|---|
| 1 month (2021-12-23) | -28.83% |
| 3 months (2021-10-25) | -32.36% |
| 6 months (2021-07-21) | N/A |
| 1 year (2021-01-21) | N/A |
|---|---|
| 2 years (2020-01-21) | N/A |
| 3 years (2019-01-21) | N/A |
| 5 years (2017-01-21) | N/A |
Valuing OLAPLEX stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of OLAPLEX's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
OLAPLEX's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 110x. In other words, OLAPLEX shares trade at around 110x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
However, OLAPLEX's P/E ratio is best considered in relation to those of others within the specialty retail industry or those of similar companies.
OLAPLEX's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $334.9 million.
The EBITDA is a measure of a OLAPLEX's overall financial performance and is widely used to measure a its profitability.
To put OLAPLEX's EBITDA into context you can compare it against that of similar companies.
| Revenue TTM | $525.1 million |
|---|---|
| Operating margin TTM | 54.51% |
| Gross profit TTM | $230.4 million |
| Return on assets TTM | 0% |
| Return on equity TTM | 0% |
| Profit margin | 35.21% |
| Book value | $0.70 |
| Market capitalisation | $13.3 billion |
TTM: trailing 12 months
We're not expecting OLAPLEX to pay a dividend over the next 12 months.
You may also wish to consider:
Olaplex Holdings, Inc. manufactures and sells hair care products. It offers hair care shampoos and conditioners for the hair treatment, maintenance, and protection. The company was founded in 2014 and is based in Santa Barbara, California. .
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut earns up to 10% APY, but you must have an iOS device.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.